08.05.2017 14:15:00
|
Cross-Industry Partnership Reduces The Cost Of Popular Diabetes, Asthma And Other Brand Name Drugs
ST. LOUIS and SANTA MONICA, Calif., May 8, 2017 /PRNewswire/ -- Today, Express Scripts (NASDAQ: ESRX) announced the launch of Inside Rx, a new, partially owned subsidiary that applies Express Scripts' purchasing power to expand affordable access to brand and generic medications for patients in need. Inside Rx has partnered with GoodRx, America's leading source for prescription drug prices and savings, to deliver average savings of 34 percent on prescription medications for the uninsured and those who experience high out-of-pocket costs for their prescription medications.
Beginning today, patients can visit www.goodrx.com/brand or download the GoodRx mobile app to instantly access significant savings for more than 40 popular brand name drugs that treat diabetes, asthma, heart disease, depression, gastrointestinal disorders, gout, and other common illnesses. While savings vary per drug and pharmacy, eligible patients can save an average of 34 percent off of the drug's typical cash price, which could translate into savings of hundreds or even thousands of dollars per person per year.
Benefiting from these discounts is easy; eligible patients simply present the discount via card or mobile app at one of 40,000 pharmacies nationwide, including CVS, the Kroger Family of Pharmacies and Walgreens. There are no membership fees or costs to obtain savings. A complete list of available medications and participating pharmacies are available at www.insiderx.com.
"We have a unique opportunity to put medicine within reach of those who need it. By practicing pharmacy smarter, we are bringing together companies across healthcare to truly deliver value," said Express Scripts President and CEO Tim Wentworth. "We are proud to power a novel solution that makes brand-name medicines more affordable and accessible, particularly for people without prescription coverage."
The program represents an important, and unique, cross-industry collaboration among Inside Rx, GoodRx, participating retail pharmacies, and major pharmaceutical companies, including Boehringer Ingelheim, Eli Lilly and Company, Lundbeck, Novo Nordisk, Sanofi, Takeda Pharmaceuticals and Teva Pharmaceuticals. All stakeholders share a focus to ensure patients have expanded access to affordable medications. Today, more than 30 million Americans pay the full cost of their prescriptions.
"The GoodRx / Inside Rx program is a simple and effective way to help millions of Americans who struggle to afford their prescriptions," said Doug Hirsch, co-founder and co-CEO of GoodRx. "GoodRx is proud to partner with Inside Rx to reduce the cost of diabetes, asthma and other important drugs that patients need."
"We are pleased to participate in Express Scripts' new program that will play an important role in helping under-insured and uninsured patients receive the medicines they need at a price they can afford," said Brad Fluegel, Senior Vice President, Chief Healthcare Commercial Market Development Officer, Walgreens.
"Kroger is excited to partner with Express Scripts on this new program that creates affordability and expands access to medications for many of our patients," said Colleen Lindholz, President of Pharmacy and The Little Clinic, The Kroger Co. Soon, Inside Rx cards also will be available at the Kroger Family of Pharmacy locations.
Inside Rx is not insurance, and is not available to members enrolled in government-sponsored health programs, such as Medicare, Medicaid or TRICARE. Patients with a high-deductible insurance plan should review their coverage details to determine if the discount available through Inside Rx is right for them.
About Express Scripts
Express Scripts puts medicine within reach of tens of millions of people by aligning with plan sponsors, taking bold action and delivering patient-centered care to make better health more affordable and accessible.
Headquartered in St. Louis, Express Scripts provides integrated pharmacy benefit management services, including network-pharmacy claims processing, home delivery pharmacy care, specialty pharmacy care, specialty benefit management, benefit-design consultation, drug utilization review, formulary management, and medical and drug data analysis services. Express Scripts also distributes a full range of biopharmaceutical products and provides extensive cost-management and patient-care services.
For more information, visit Lab.Express-Scripts.com or follow @ExpressScripts on Twitter.
About Inside Rx
Headquartered in Franklin Lakes, New Jersey, Inside Rx provides affordable access to medication, especially for the uninsured and those navigating the changing healthcare landscape.
Inside Rx delivers broad access to more affordable branded medications. This program works collaboratively across the pharmacy supply chain, with all parties sharing a singular focus: to ensure patients have affordable access to medication they need.
Inside Rx is powered by our parent company, Express Scripts, the nation's leading independent pharmacy benefit manager.
To view a list of medications and participating pharmacies, and eligibility information, visit InsideRx.com. You can also follow @Inside_Rx on Twitter.
About GoodRx
Every day, GoodRx brings millions of Americans the lowest possible prices for prescription drugs. The company's proprietary market-intelligence technology evaluates available pricing at more than 70,000 pharmacies to bring customers up to 80% savings on their prescriptions; since 2011, Americans have saved more than $2 billion using GoodRx services. With GoodRx, Americans can finally compare prices and locations to find the best place to fill their prescriptions. The company's products, including the #1 medical app in the App Store, are free and available to all Americans, insured or not. For more information, visit www.GoodRx.com.
Media Contact:
Jennifer Luddy, Express Scripts
201-269-6402
Jennifer_Luddy@express-scripts.com
Jocelyn Westerhold, GoodRx
631-645-4751
Jocelyn@alissaneilpr.com
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/cross-industry-partnership-reduces-the-cost-of-popular-diabetes-asthma-and-other-brand-name-drugs-300453059.html
SOURCE Express Scripts
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Express Scripts Holding Comehr Nachrichten
Keine Nachrichten verfügbar. |